77 related articles for article (PubMed ID: 2711816)
1. [Immunohistology and prognosis in thyroid cancer. Determination of the malignancy potential of papillary and medullary neoplasms by the detection of S-100 protein and Leu-M1 antigen].
Schröder S; Dralle H; Bay V; Böcker W
Acta Med Austriaca; 1989; 16(1):2-5. PubMed ID: 2711816
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in medullary thyroid carcinomas.
Schröder S; Dralle H
Horm Metab Res Suppl; 1989; 21():26-8. PubMed ID: 2807152
[TBL] [Abstract][Full Text] [Related]
3. [The importance of S-100 protein positive Langerhans cells and Leu-M1 positive tumor cells for prognosis of papillary thyroid cancer].
Willgeroth C; Floegel R; Rösler B
Zentralbl Chir; 1992; 117(11):603-6. PubMed ID: 1361703
[TBL] [Abstract][Full Text] [Related]
4. [Pathological and clinical features of malignant thyroid tumors: classification, immunohistology, prognostic criteria].
Schröder S
Veroff Pathol; 1988; 130():1-159. PubMed ID: 3213226
[TBL] [Abstract][Full Text] [Related]
5. Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinomas. Immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data.
Schröder S; Schwarz W; Rehpenning W; Löning T; Böcker W
Am J Clin Pathol; 1988 Mar; 89(3):295-300. PubMed ID: 3348166
[TBL] [Abstract][Full Text] [Related]
6. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of Leu-M1 immunostaining in papillary carcinomas of the thyroid gland.
Schröder S; Schwarz W; Rehpenning W; Löning T; Böcker W
Virchows Arch A Pathol Anat Histopathol; 1987; 411(5):435-9. PubMed ID: 3116758
[TBL] [Abstract][Full Text] [Related]
8. Leu-M1 immunoreactivity and prognosis in medullary carcinomas of the thyroid gland.
Schröder S; Schwarz W; Rehpenning W; Dralle H; Bay V; Böcker W
J Cancer Res Clin Oncol; 1988; 114(3):291-6. PubMed ID: 3260237
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of the expression of S-100 protein, epithelial membrane antigen, cytokeratin and carcinoembryonic antigen in thyroid lesions.
Mitselou A; Vougiouklakis TG; Peschos D; Dallas P; Boumba VA; Agnantis NJ
Anticancer Res; 2002; 22(3):1777-80. PubMed ID: 12168868
[TBL] [Abstract][Full Text] [Related]
10. [Small thyroid carcinomas: biological characteristics, diagnosis and therapy].
Gemsenjäger E; Schweizer I
Schweiz Med Wochenschr; 1999 May; 129(18):681-90. PubMed ID: 10407941
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
[TBL] [Abstract][Full Text] [Related]
12. [Differentiated carcinoma of the thyroid gland. Anatomo-clinical characteristics].
Pandolfi C
Minerva Med; 1986 Jun; 77(27):1309-16. PubMed ID: 3725154
[TBL] [Abstract][Full Text] [Related]
13. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
[TBL] [Abstract][Full Text] [Related]
14. Unusual tumors of the thyroid gland.
Baloch ZW; LiVolsi VA
Endocrinol Metab Clin North Am; 2008 Jun; 37(2):297-310, vii. PubMed ID: 18502328
[TBL] [Abstract][Full Text] [Related]
15. Retinoblastoma expression in thyroid neoplasms.
Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
[TBL] [Abstract][Full Text] [Related]
16. Expression of S100A2 and S100A6 in thyroid carcinomas.
Ito Y; Yoshida H; Tomoda C; Uruno T; Miya A; Kobayashi K; Matsuzuka F; Kakudo K; Kuma K; Miyauchi A
Histopathology; 2005 May; 46(5):569-75. PubMed ID: 15842639
[TBL] [Abstract][Full Text] [Related]
17. Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases.
Wenig BM; Thompson LD; Adair CF; Shmookler B; Heffess CS
Cancer; 1998 Feb; 82(4):740-53. PubMed ID: 9477108
[TBL] [Abstract][Full Text] [Related]
18. Pathologic diagnosis of papillary thyroid carcinoma: today and tomorrow.
Baloch ZW; LiVolsi VA
Expert Rev Mol Diagn; 2005 Jul; 5(4):573-84. PubMed ID: 16013975
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic molecular biology in solid tumors--thyroid gland].
Faksvåg Haugen DR; Varhaug JE; Akslen LA; Lillehaug JR
Tidsskr Nor Laegeforen; 1998 May; 118(14):2199-203. PubMed ID: 9656818
[TBL] [Abstract][Full Text] [Related]
20. [Poorly differentiated carcinoma of the thyroid--immunohistochemical evaluation of p53 and p27 protein expression].
Wierzchowski W; Szybiński P; Nowak W; Nowak K; Szybiński Z; Buziak-Bereza M; Stachura J
Wiad Lek; 2001; 54 Suppl 1():79-87. PubMed ID: 12182066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
